ISPOR 2015 SCIENTIFIC AWARDS - CALL FOR NOMINATIONS

Published Jan 6, 2015
Awards The ISPOR Awards Committee is now accepting nominations for the Society’s annual scientific awards.  ISPOR’s Scientific Awards are designed to recognize outstanding achievements in pharmacoeconomics and outcomes research. If you would like to nominate a candidate or yourself for one of the four awards, please send the required nomination materials to: awards@ispor.org by FRIDAY, FEBRUARY 13, 2015. The ISPOR Scientific Awards are:
Avedis Donabedian Lifetime Achievement Award Recognizes an individual's outstanding, life-long achievement in the area of improving health outcomes.
ISPOR Marilyn Dix Smith Leadership Award Recognizes an individual that has provided extraordinary leadership to the Society.
ISPOR Bernie J. O’Brien New Investigator Award Recognizes an individual’s contribution to training and mentoring new scientists in the fields of outcomes research and pharmacoeconomics.
Excellence in Methodology in Pharmacoeconomics and Health Outcomes Research Award Recognizes outstanding research in the field of pharmacoeconomics and outcomes research methodology.
Excellence in Application of Pharmacoeconomics and Health Outcomes Research Award Recognizes outstanding practical application of pharmacoeconomics and outcomes research in health care decision making.
(Nomination requirements and detailed award descriptions can be found at the ISPOR website at: http://www.ispor.org/awards/index_.asp.) These awards will be presented at the ISPOR 20th Annual International Meeting in Philadelphia, PA, USA, May 16-20, 2015. To learn more about this meeting, or to register, please visit: ISPOR 20th Annual International Meeting.  

Related Stories

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.

How Is Health Valued in the United Kingdom? We Finally Have a Better Answer

May 27, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a pair of companion articles that together establish both the methodological foundation of the first definitive UK value set for the EQ-5D-5L and the practical implications of adopting it—thus equipping health technology assessment decision makers with a UK value set suitable for informing policy. The articles were featured in the May 2026 issue of Value in Health.

ISPOR Announces 2026-2027 Board of Directors

May 26, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research announced its 2026-2027 board of directors who will assume office on July 1, 2026.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×